Co-Authors
This is a "connection" page, showing publications co-authored by Michael Gottlieb and Robert Weinstein.
Connection Strength
1.798
-
Differences in Long COVID severity by duration of illness, symptom evolution, and vaccination: a longitudinal cohort study from the INSPIRE group. Lancet Reg Health Am. 2025 Apr; 44:101026.
Score: 0.977
-
Severe Fatigue and Persistent Symptoms at 3 Months Following Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study. Clin Infect Dis. 2023 06 08; 76(11):1930-1941.
Score: 0.217
-
Long COVID Clinical Phenotypes up to 6 Months After Infection Identified by Latent Class Analysis of Self-Reported Symptoms. Open Forum Infect Dis. 2023 Jul; 10(7):ofad277.
Score: 0.217
-
Assessment of health conditions from patient electronic health record portals vs self-reported questionnaires: an analysis of the INSPIRE study. J Am Med Inform Assoc. 2025 May 01; 32(5):784-794.
Score: 0.062
-
Association of binge alcohol use with functional outcomes among individuals with COVID-19 infection. Alcohol Alcohol. 2024 Nov 18; 60(1).
Score: 0.060
-
Prevalence of Symptoms =12 Months After Acute Illness, by COVID-19 Testing Status Among Adults - United States, December 2020-March 2023. MMWR Morb Mortal Wkly Rep. 2023 Aug 11; 72(32):859-865.
Score: 0.055
-
Association Between SARS-CoV-2 Variants and Frequency of Acute Symptoms: Analysis of a Multi-institutional Prospective Cohort Study-December 20, 2020-June 20, 2022. Open Forum Infect Dis. 2023 Jul; 10(7):ofad275.
Score: 0.054
-
Three-Month Symptom Profiles Among Symptomatic Adults With Positive and Negative Severe Acute Respiratory Syndrome Coronavirus 2 Tests: A Prospective Cohort Study From the INSPIRE Group. Clin Infect Dis. 2023 05 03; 76(9):1559-1566.
Score: 0.054
-
Association of Initial SARS-CoV-2 Test Positivity With Patient-Reported Well-being 3 Months After a Symptomatic Illness. JAMA Netw Open. 2022 12 01; 5(12):e2244486.
Score: 0.052
-
Study protocol for the Innovative Support for Patients with SARS-COV-2 Infections Registry (INSPIRE): A longitudinal study of the medium and long-term sequelae of SARS-CoV-2 infection. PLoS One. 2022; 17(3):e0264260.
Score: 0.050